SCHEMBL1007264

SCHEMBL1007264

CCCCC([O])C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1007253 0.92 LCK (0.61)
SCHEMBL1006544 0.90 LCK (0.65)
SCHEMBL1006947 0.90 LCK (0.65)
SCHEMBL1006814 0.90 LCK (0.65)
SCHEMBL1005572 0.90 LCK (0.65)
SCHEMBL1008879 0.90 LCK (0.65)
SCHEMBL1006839 0.90 LCK (0.65)
SCHEMBL1007208 0.90 LCK (0.65)
SCHEMBL1008153 0.90 LCK (0.65)
SCHEMBL1007485 0.90 LCK (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107624113-B Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of HBsAg (HBV surface antigen) and HBV DNA production for the treatment of hepatitis B virus infection 豪夫迈·罗氏有限公司 2020-10-23 CN claimed
EP-3292120-B1 TETRAHYDROPYRIDOPYRIMIDINES AND TETRAHYDROPYRIDOPYRIDINES AS INHIBITORS OF HBSAG (HBV SURFACE ANTIGEN) AND HBV DNA PRODUCTION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS HOFFMANN LA ROCHE (CH) 2019-06-19 EP claimed
EP-3292120-A1 TETRAHYDROPYRIDOPYRIMIDINES AND TETRAHYDROPYRIDOPYRIDINES AS INHIBITORS OF HBSAG (HBV SURFACE ANTIGEN) AND HBV DNA PRODUCTION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS H. Hoffnabb-La Roche Ag (CH) 2018-03-14 EP claimed
US-9845322-B2 Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infection HOFFMANN-LA ROCHE INC. (US) 2017-12-19 US claimed
WO-2016177655-A1 TETRAHYDROPYRIDOPYRIMIDINES AND TETRAHYDROPYRIDOPYRIDINES AS INHIBITORS OF HBSAG (HBV SURFACE ANTIGEN) AND HBV DNA PRODUCTION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS F. HOFFMANN-LA ROCHE AG (CH) 2016-11-10 WO claimed
US-20160326167-A1 Novel Tetrahydropyridopyrimidines and Tetrahydropyridopyridines for the Treatment and Prophylaxis of Hepatitis B Virus Infection HOFFMANN-LA ROCHE INC. (US) 2016-11-10 US claimed
US-6737389-B1 Method for treating textile Coöperatie Cosun U.A. (NL) 2004-05-18 US claimed
EP-1084216-B1 METHOD FOR TREATING TEXTILE COOPERATIE COSUN U A (NL) 2003-01-08 EP claimed
EP-1084216-A1 METHOD FOR TREATING TEXTILE Coöperatie Cosun U.A. (NL) 2001-03-21 EP claimed
WO-1999064551-A1 METHOD FOR TREATING TEXTILE Coöperatie Cosun U.A. (NL) 1999-12-16 WO claimed
WO-1998025972-A1 FRUCTAN-POLYCARBOXYLIC ACID COOPERATIE COSUN U.A. (NL) 1998-06-18 WO claimed
EP-0044105-B1 NEW 8-ALPHA-OESTRA-1,3,5(10)-TRIENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS AKZO N.V. (NL) 1984-10-03 EP claimed
EP-0044105-A2 New 8-alpha-oestra-1,3,5(10)-triene derivatives, processes for their preparation and pharmaceutical compositions AKZO N.V. (NL) 1982-01-20 EP claimed
EP-4219767-A1 PAPD5 AND PAPD7 INHIBITORS FOR TREATING A HEPATITIS B INFECTION F. Hoffmann-La Roche AG (CH) 2023-08-02 EP disclosed
CN-109328237-B Inhibitors of PAPD5 and PAPD7 for the treatment of hepatitis b infection 豪夫迈·罗氏有限公司 2022-12-06 CN disclosed
US-20220096527-A1 PAPD5 AND PAPD7 INHIBITORS FOR TREATING A HEPATITIS B INFECTION HOFFMANN-LA ROCHE INC. (US) 2022-03-31 US disclosed
WO-1998034603-A1 USE OF BETULIN AND ANALOGS THEREOF TO TREAT HERPESVIRUS INFECTION REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 1998-08-13 WO disclosed
EP-0014005-B1 NOVEL ALKYLATED PREGNANES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AKZO N.V. (NL) 1983-08-03 EP disclosed
US-4260605-A ANTIINFLAMMATORY AGENTS, SULFONATION AND SUBSEQUENT ACYLATION OF SUBSTITUTED PREGNANE AKZO N.V. (NL) 1981-04-07 US disclosed
EP-0014005-A1 Novel alkylated pregnanes, processes for their preparation and pharmaceutical compositions containing same AKZO N.V. (NL) 1980-08-06 EP disclosed